本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Evaxion Biotech A/S

3.07
-0.0600-1.92%
盤後3.200.1300+4.23%16:28 EDT
成交量:2.19萬
成交額:6.82萬
市值:2,560.44萬
市盈率:-2.82
高:3.17
開:3.17
低:3.07
收:3.13
52周最高:12.15
52周最低:2.77
股本:834.02萬
流通股本:553.19萬
量比:0.39
換手率:0.40%
股息:- -
股息率:- -
每股收益(TTM):-1.0886
每股收益(LYR):-1.2027
淨資產收益率:-109.86%
總資產收益率:-25.97%
市淨率:2.69
市盈率(LYR):-2.55

資料載入中...

2024/01/30

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/01/23

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/12

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2023/04/28

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/08/24

SEC問詢函

CORRESP [Cover] - Correspondence
2022/08/22

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/07/07

招股説明書

F-1 - Registration statement for certain foreign private issuers
2022/06/01

SEC問詢函

CORRESP [Cover] - Correspondence
2022/03/31

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/10/29

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/29

SEC問詢函

CORRESP [Cover] - Correspondence
2021/10/26

招股説明書

F-1 - Registration statement for certain foreign private issuers
2021/05/13

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/04/07

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/06

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/04/06

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/02

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/02

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/01

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/02/01

SEC問詢函

CORRESP [Cover] - Correspondence